{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:03:15Z","timestamp":1792198995866,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Plan of Hunan Province","award":["2015RS4002"],"award-info":[{"award-number":["2015RS4002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.msec.2017.04.049","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T12:33:48Z","timestamp":1491654828000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel"],"prefix":"10.1016","volume":"78","author":[{"given":"Yongju","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuquan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2017.04.049_bb0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11095-015-1827-7","article-title":"Glucose-based mesoporous carbon nanospheres as functional carriers for oral delivery of amphiphobic raloxifene: insights into the bioavailability enhancement and lymphatic transport","volume":"33","author":"Ye","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.msec.2017.04.049_bb0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2012.02.012","article-title":"Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption","volume":"81","author":"Beig","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0015","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1021\/jp201053d","article-title":"Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery","volume":"115","author":"Yuan","year":"2011","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.msec.2017.04.049_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v33.i1.20","article-title":"Current trends in self-emulsifying drug-delivery systems (SEDDSs) to enhance the bioavailability of poorly water-soluble drugs","volume":"33","author":"Karwal","year":"2016","journal-title":"Crit. Rev. Ther. Drug"},{"key":"10.1016\/j.msec.2017.04.049_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2016.07.011","article-title":"Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine","volume":"511","author":"Bruni","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.msec.2016.02.046","article-title":"Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: optimization and physicochemical investigations","volume":"63","author":"Mishra","year":"2016","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.msec.2017.04.049_bb0035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.msec.2010.05.001","article-title":"Enhanced solubility and dissolution rate of amiodarone by complexation with beta-cyclodextrin through different methods","volume":"30","author":"Riekes","year":"2010","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.msec.2017.04.049_bb0040","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.msec.2015.09.019","article-title":"Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability","volume":"58","author":"Desai","year":"2016","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.msec.2017.04.049_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.msec.2015.12.098","article-title":"Hydroxypropyl-beta-cyclodextrin-graphene oxide conjugates: carriers for anti-cancer drugs","volume":"61","author":"Tan","year":"2016","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.msec.2017.04.049_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2014.08.047","article-title":"Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo","volume":"475","author":"Yang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2015.11.029","article-title":"Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram","volume":"497","author":"Shergill","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s13346-016-0307-x","article-title":"Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug","volume":"6","author":"Malipeddi","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.msec.2017.04.049_bb0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejps.2013.03.008","article-title":"Nanocarrier systems for oral drug delivery: do we really need them?","volume":"49","author":"Bernkop-Schnurch","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msec.2017.04.049_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejps.2013.02.023","article-title":"Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels","volume":"50","author":"Valo","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msec.2017.04.049_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.matlet.2010.08.078","article-title":"Synthesis of large-pore periodic mesoporous organosilica","volume":"65","author":"Hu","year":"2011","journal-title":"Mater. Lett."},{"key":"10.1016\/j.msec.2017.04.049_bb0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2010.07.040","article-title":"Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties","volume":"410","author":"Zhang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejps.2012.10.012","article-title":"Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro\/in vivo correlations in beagle dogs","volume":"48","author":"Cao","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msec.2017.04.049_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.01.058","article-title":"In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes","volume":"445","author":"Jia","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0095","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/adfm.201100510","article-title":"Iron oxide nanotubes for magnetically guided delivery and pH-activated release of insoluble anticancer drugs","volume":"21","author":"Yue","year":"2011","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.msec.2017.04.049_bb0100","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1039\/c0jm00726a","article-title":"Fabrication of magnetite hollow porous nanocrystal shells as a drug carrier for paclitaxel","volume":"20","author":"Luo","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.msec.2017.04.049_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2016.04.019","article-title":"The application of mesoporous silica nanoparticle family in cancer theranostics","volume":"319","author":"Feng","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.msec.2017.04.049_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.nano.2015.10.018","article-title":"Advances in silica based nanoparticles for targeted cancer therapy","volume":"12","author":"Yang","year":"2016","journal-title":"Nanomed.-Nanotechnol."},{"key":"10.1016\/j.msec.2017.04.049_bb0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","article-title":"Mesoporous silica nanoparticles in drug delivery and biomedical applications","volume":"11","author":"Wang","year":"2015","journal-title":"Nanomed.-Nanotechnol."},{"key":"10.1016\/j.msec.2017.04.049_bb0120","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1021\/acs.langmuir.6b01715","article-title":"Polyglutamic acid-gated mesoporous silica nanoparticles for enzyme-controlled drug delivery","volume":"32","author":"Tukappa","year":"2016","journal-title":"Langmuir"},{"key":"10.1016\/j.msec.2017.04.049_bb0125","doi-asserted-by":"crossref","first-page":"26511","DOI":"10.1021\/acsami.6b08400","article-title":"Rational design of multifunctional dendritic mesoporous silica nanoparticles to load curcumin and enhance efficacy for breast cancer therapy","volume":"8","author":"Wang","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2017.04.049_bb0130","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.bbagen.2016.07.001","article-title":"Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells","volume":"1860","author":"Sarkar","year":"2016","journal-title":"BBA-Gen. Subjects"},{"key":"10.1016\/j.msec.2017.04.049_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.micromeso.2003.12.012","article-title":"Influence of pore size of MCM-41 matrices on drug delivery rate","volume":"68","author":"Horcajada","year":"2004","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.msec.2017.04.049_bb0140","article-title":"Core-shell nanocarriers with high paclitaxel loading for passive and active targeting","volume":"6","author":"Jin","year":"2016","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.msec.2017.04.049_bb0145","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.msec.2017.04.049_bb0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.msec.2017.04.049_bb0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ajps.2015.05.001","article-title":"Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug","volume":"10","author":"Ganesan","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.msec.2017.04.049_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.matlet.2014.06.026","article-title":"Fabrication of mesoporous spherical silica nanoparticles and effects of synthesis conditions on particle mesostructure","volume":"131","author":"He","year":"2014","journal-title":"Mater. Lett."},{"key":"10.1016\/j.msec.2017.04.049_bb0165","article-title":"Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo","volume":"6","author":"Jin","year":"2016","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.msec.2017.04.049_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10406638.2014.918551","article-title":"PAH and IUPAC nomenclature","volume":"35","author":"Ehrenhauser","year":"2015","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.msec.2017.04.049_bb0175","doi-asserted-by":"crossref","DOI":"10.1142\/S1793292015300042","article-title":"Nanoscale drug delivery systems: a current review on the promising paclitaxel formulations for future cancer therapy","volume":"10","author":"Fang","year":"2015","journal-title":"Nano"},{"key":"10.1016\/j.msec.2017.04.049_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2010.04.029","article-title":"Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan","volume":"145","author":"Zhang","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2017.04.049_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2012.10.011","article-title":"Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs","volume":"439","author":"Jia","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0190","first-page":"99","article-title":"Evaluation of mass spectra from organic compounds assumed to be present in cometary grains. Exploratory data analysis","volume":"16","author":"Werther","year":"2002","journal-title":"J. Chemother."},{"key":"10.1016\/j.msec.2017.04.049_bb0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.micromeso.2016.08.014","article-title":"Improved solubility of celecoxib by inclusion in SBA-15 mesoporous silica: drug loading in different solvents and release","volume":"235","author":"Eren","year":"2016","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.msec.2017.04.049_bb0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.colsurfb.2016.02.013","article-title":"Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica","volume":"141","author":"Quan","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.msec.2017.04.049_bb0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijpharm.2010.05.008","article-title":"Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance","volume":"395","author":"Liu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2017.04.049_bb0210","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1208\/s12249-008-9063-7","article-title":"A novel nanoparticle formulation for sustained paclitaxel delivery","volume":"9","author":"Trickler","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.msec.2017.04.049_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-8-212","article-title":"Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity","volume":"8","author":"Vicari","year":"2008","journal-title":"BMC Cancer"}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116321889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493116321889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T17:24:57Z","timestamp":1535909097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493116321889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":43,"alternative-id":["S0928493116321889"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2017.04.049","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2017.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}